P HLA Protein Logo (WIPO, 03/11/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark P HLA Protein was filed as Figurative mark on 03/11/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Quadrilaterals #Letters presenting a special form of writing #Several quadrilaterals juxtaposed, joined or intersecting #Quadrilaterals with dark surfaces or parts of surfaces
| Trademark form | Figurative mark |
| File reference | 1598120 |
| Countries | 
|
| Base trademark |
No. 90252361,
October 13, 2020
|
| Application date | March 11, 2021 |
| Expiration date | March 11, 2031 |
Trademark owner
Building Two, Suite 260
7500 Rialto Blvd.
US
7500 Rialto Blvd.
US
Trademark representatives
2040 Main Street, 14th Floor
Irvine CA 92614
US
goods and services
01
Reagents for scientific, pharmaceutical, clinical, and
medical research purposes; laboratory chemicals, namely,
protein-based reagents used for the detection of antibodies
and receptors in cell, blood, and tissue analysis for in
vitro diagnostics for scientific use and research in the
field of therapeutic reagent designs; chemicals and
biochemicals in the nature of reactants and reagents for in
vitro scientific or research use; chemicals and biochemicals
for use in the manufacture of pharmaceutical preparations;
chemical, biochemical and biotechnological solutions and
preparations consisting of pre-mixed reactants and reagents
for scientific and research use in connection with antibody
and B or T cell detection, separation and labelling;
biochemical reagents for detecting and analyzing molecules
in protein arrays; diagnostic reagents for in vitro use in
biochemistry, clinical chemistry and microbiology; chemical,
biochemical and biotechnological products in the nature of
reactants and reagents for use in biotechnological product
development of therapeutics for the prevention and treatment
of cancer, infectious diseases, autoimmune diseases and
allergies; chemical, biochemical and biotechnological
preparations used in industry and science, and in the
development and manufacture of pharmaceuticals,
pharmaceutical preparations and substances, for the
prevention and treatment of cancer, infectious diseases,
autoimmune diseases and allergies; chemical, biochemical and
biotechnological preparations used in industry and science,
and in the development and manufacture of pharmaceuticals,
pharmaceutical preparations and substances, for the
detection, prevention and treatment of rejection causing
antibodies, B and T cells
05
Chemicals and biochemicals for in vitro clinical and medical
use
42
Providing scientific, pharmaceutical, clinical, and medical
research information via the internet; research and
development of new products; pharmaceutical drug and
biomarker preparation target discovery, development, and
validation in the nature of research, development, and
quality assurance services; pharmaceutical and scientific
research and development services; medical research
services; medical development services in the fields of
pharmaceuticals, biology, chemistry, biochemistry,
biotechnology, and clinical trials; clinical research
services in the fields of pharmaceuticals, biology,
chemistry, biochemistry, and clinical trials; clinical
development services in the nature of scientific development
of clinical trials; consulting services in the field of
pharmaceutical assessment; scientific and medical research
consulting services for transplant and organ rejection
assessment; validation in the nature of quality assurance
services, screening and mapping in the nature of scientific
research and development of biological material for drug
discovery and vaccine manufacturing purposes; providing
scientific information and medical research information in
the fields of pharmaceuticals, biology, chemistry,
biochemistry, biotechnology, and clinical trials; scientific
and medical research and development in the field of cancer,
infectious diseases, autoimmune diseases and allergies;
scientific and medical research and development in the field
of antibody, B cell and T cell detection in transplant and
organ rejection
44
Medical consulting services for transplant and organ
rejection assessment
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 18, 2021 | 2021/48 Gaz | EM | Rejection |
| November 17, 2021 | 2021/46 Gaz | GB | Rejection |
| March 11, 2021 | 2021/23 Gaz | US | Registration |
ID: 141598120